Moreover, CD8+ T cells, which were mainly associated with anti-tumor activity, showed higher infiltration levels in RBM10 deficient LUADs, while CD4+T cells showed lower infiltration levels in these cases, suggesting that the elevated immune activity in RBM10 deficient LUADs specifically targeted cancer cells. This evidence concerns the gene CD8A and cancer.